Nathalie Vargas
Physician Assistant · Bay Shore, NYNPI 1851836704
Payments from drug & device makers
Across 209 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$432
- Amarin Pharma, Inc.$388
- Amgen$321
- GSK$256
- Redhill Biopharma Inc.$250
- plus $947 from 18 others
What the payments were for
- Food & beverage$3,722100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $1,128 |
| AstraZeneca | 25 | $432 |
| Amarin Pharma, Inc. | 19 | $388 |
| Amgen(2 entities) | 15 | $321 |
| GSK | 13 | $256 |
| Redhill Biopharma Inc. | 14 | $250 |
| Lilly USA, LLC | 11 | $186 |
| Abbott | 9 | $159 |
| Exact Sciences | 6 | $138 |
| Daiichi Sankyo Inc. | 4 | $72 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Shield Therapeutics Inc | 2 | $43 |
| Pfizer | 2 | $41 |
| Ironwood Pharmaceuticals, Inc | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Mannkind Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| AbbVie | 1 | $17 |
| Novartis | 1 | $14 |
| Vistapharm, Inc. | 1 | $14 |
How this compares
$3,722 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 75 | $113,466 |
| JardianceEmpagliflozin | 40 | $67,283 |
| FarxigaDapagliflozin Propanediol | 47 | $57,822 |
| EliquisApixaban | 21 | $26,981 |
| VascepaIcosapent Ethyl | 59 | $26,027 |
| ProliaDenosumab | 14 | $23,845 |
| LinzessLinaclotide | 13 | $16,428 |
| TrulicityDulaglutide | 11 | $12,243 |
| Xigduo XrDapaglifloz Propaned/Metformin | 13 | $11,786 |
| Novolog FlexpenInsulin Aspart | 20 | $7,614 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,715 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $4,602 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,477 |
| Omega-3 Acid Ethyl Esters | 49 | $2,468 |
| Rosuvastatin Calcium | 212 | $2,372 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,128 | $113,46675 claims |
| AstraZenecaFarxiga | $432 | $57,82247 claims |
| PfizerEliquis | $41 | $26,98121 claims |
| AmgenProlia | $321 | $23,84514 claims |
| AbbVieLinzess | $17 | $16,42813 claims |
| Lilly USA, LLCTrulicity | $186 | $12,24311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Bay Shore
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.